Clinical Trials
24 trialsNCT04573192 2024-04-08
GLIOSTAR
Philogen S.p.A.
Phase 1/2 Unknown
NCT03643549 2024-02-29
BORTEM-17
Haukeland University Hospital
Phase 1/2 Unknown
NCT06279767 2024-02-28
Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2 Unknown
NCT04077866 2022-12-28
B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Unknown
NCT05663125 2022-12-23
LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
Beijing Tiantan Hospital
Phase 1/2 Unknown
NCT03750071 2022-10-20
VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
Vaximm GmbH
Phase 1/2 Unknown
NCT05131711 2021-11-23
CSREIG
Beijing Tiantan Hospital
Phase 1/2 Unknown
NCT05053880 2021-11-19
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
Accendatech USA Inc.
Phase 1/2 Unknown
NCT04772846 2021-02-26
Chloroquine for Glioblastoma.
Egyptian Medical Syndicate
Phase 1/2 Unknown
NCT04388033 2020-06-09
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Unknown
NCT00275067 2020-02-25
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Northwestern University
Phase 1/2 Unknown
NCT04004975 2019-07-02
Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
Shandong Cancer Hospital and Institute
Phase 1/2 Unknown
NCT03607643 2018-07-31
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Leaf Vertical Inc.
Phase 1/2 Unknown
NCT03294486 2017-11-06
ONCOVIRAC
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Unknown
NCT02939378 2016-10-20
KGDinrGBM
Beijing Tiantan Hospital
Phase 1/2 Unknown
NCT02430363 2016-02-24
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Medical Research Council
Phase 1/2 Unknown
NCT00006460 2013-12-04
Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00014105 2013-12-04
Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00009854 2013-11-06
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT01181193 2011-03-29
Vitamin D for Treatment of Glioblastoma Multiforme
Soroka University Medical Center
Phase 1/2 Unknown
NCT00635557 2011-03-25
Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
Myrexis Inc.
Phase 1/2 Unknown
NCT00683761 2009-07-17
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
TransMolecular
Phase 1/2 Unknown
NCT00394628 2007-05-30
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Novacea
Phase 1/2 Unknown
NCT00311857 2006-09-08
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
Heidelberg University
Phase 1/2 Unknown